Gan & Lee Pharmaceuticals. (SHA:603087)
China flag China · Delayed Price · Currency is CNY
60.14
+0.16 (0.27%)
May 8, 2026, 3:00 PM CST

SHA:603087 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,1652,088902.782,4432,8903,306
Short-Term Investments
----201.36276.44
Trading Asset Securities
1,2511,4011,5002,4101,6361,624
Cash & Short-Term Investments
3,4163,4892,4034,8534,7285,206
Cash Growth
44.96%45.20%-50.48%2.66%-9.20%14.24%
Accounts Receivable
447.85599.87213.71383.74189.57934.66
Other Receivables
5.823.7631.891.630.990.16
Receivables
453.67603.63245.6385.37190.55934.82
Inventory
1,0901,0091,053860.51648.65651.33
Other Current Assets
442.44382.3289.0776.7397.3677.95
Total Current Assets
5,4035,4843,7916,1765,6646,870
Property, Plant & Equipment
3,5143,5773,8823,8863,6612,595
Long-Term Investments
479.31520.53497.03304.6630201.36
Other Intangible Assets
509.39265.11273.06278.08293.48295.99
Long-Term Deferred Tax Assets
220.36213.67206.94168.95138.2530.8
Long-Term Deferred Charges
1,5791,611924.91821.97743.19588.87
Other Long-Term Assets
974.67954.722,46879.9976.51270.33
Total Assets
12,68012,62712,04311,71510,60710,853
Accounts Payable
147.71134.41115.6194.8236.5226.15
Accrued Expenses
156.97187.26183.44192.54190173.04
Current Portion of Long-Term Debt
8.278.99----
Current Portion of Leases
--1.332.185.695.07
Current Income Taxes Payable
34.450.871.491.421.35106.32
Current Unearned Revenue
54.9667.8863.2552.9968.1336.56
Other Current Liabilities
274.22366.37436429.49511.36138.39
Total Current Liabilities
676.53815.79801.13773.45813.04485.53
Long-Term Leases
2.272.543.315.458.3312.17
Long-Term Unearned Revenue
169.9170.75168.92179.63187.63141.98
Long-Term Deferred Tax Liabilities
--12.11--36.15
Other Long-Term Liabilities
2.969.52.971412.2710.2
Total Liabilities
851.65998.57988.45972.521,021686.02
Common Stock
597.3597.3601.07594.16565.65561.54
Additional Paid-In Capital
3,5393,5343,5913,3512,5632,476
Retained Earnings
7,7987,6067,0596,8656,5257,133
Treasury Stock
-111.17-111.17-200.85-71.36-71.36-
Comprehensive Income & Other
2.53.064.043.823.44-3.44
Total Common Equity
11,82611,62811,05410,7439,58610,167
Minority Interest
1.98--0-0.16-0.16
Shareholders' Equity
11,82811,62811,05410,7439,58610,167
Total Liabilities & Equity
12,68012,62712,04311,71510,60710,853
Total Debt
10.5411.534.647.6214.0117.24
Net Cash (Debt)
3,4063,4782,3994,8464,7145,189
Net Cash Growth
44.70%45.00%-50.50%2.80%-9.16%13.86%
Net Cash Per Share
5.765.874.068.558.379.25
Filing Date Shares Outstanding
583.29591.12598.96590.05561.54561.54
Total Common Shares Outstanding
583.29591.12598.96590.05561.54561.54
Working Capital
4,7264,6682,9905,4024,8516,385
Book Value Per Share
20.2719.6718.4618.2117.0718.11
Tangible Book Value
11,31711,36310,78110,4649,2929,871
Tangible Book Value Per Share
19.4019.2218.0017.7316.5517.58
Buildings
--2,1371,3441,1651,046
Machinery
--1,6011,4431,2371,263
Construction In Progress
--1,2622,0072,003874.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.